1. Home /
  2. Biotechnology

Biotechnology

Eli Lilly's Must-Hold Level on Drug-Data Pullback

Eli Lilly's Must-Hold Level on Drug-Data Pullback

Eli Lilly stock is falling on the day after releasing clinical trial data. Here's the must-hold spot for LLY stock now.

Acadia Pharmaceuticals Surges on Positive Trial Results for Psychosis Treatment

Acadia Pharmaceuticals Surges on Positive Trial Results for Psychosis Treatment

Acadia Pharmaceuticals rockets higher after it announces it has ended a phase 3 trial of its dementia-related psychosis treatment, pimavanserin, on better-than-expected results.

These 2 Biotech Stocks Are Seeing Insider Buying Activity

These 2 Biotech Stocks Are Seeing Insider Buying Activity

We're focused on Progenics Pharmaceuticals and Aerie Pharmaceuticals.

Eli Lilly's Lung Cancer Treatment Candidate Shows Strong Results in Trial

Eli Lilly's Lung Cancer Treatment Candidate Shows Strong Results in Trial

Lilly acquired the drug as part of its $8 billion acquisition of Loxo Oncology.

A Sagging Drugmaker and Lagging Pet Health Name Both Worth Looks

A Sagging Drugmaker and Lagging Pet Health Name Both Worth Looks

Alexion Pharmaceuticals and Elanco Animal Health have seen their shares go to the dogs of late, but still offer reasons for portfolio consideration.

There's Value In These 2 Small Beaten Down Biotech Stocks

There's Value In These 2 Small Beaten Down Biotech Stocks

Both stocks have seen some recent insider buying.

AbbVie Discontinues Phase III Trial of Drug to Treat Small-Cell Lung Cancer

AbbVie Discontinues Phase III Trial of Drug to Treat Small-Cell Lung Cancer

Rova-T failed to show a survival benefit for patients when compared with a placebo.

These 5 Small Caps Are Well Positioned Despite Escalating Trade Tensions

These 5 Small Caps Are Well Positioned Despite Escalating Trade Tensions

They're the kind of names, along with a big dollop of cash in my portfolio, I plan to wait out the 'trade wars'.

Lannett to Be U.S. Distributor of Posaconazole Delayed-Release Tablets

Lannett to Be U.S. Distributor of Posaconazole Delayed-Release Tablets

The company will be the exclusive U.S. distributor of fungal disease medication Posaconazole delayed-release tablets.

I Smell a Great Stock in a Stinky Market

I Smell a Great Stock in a Stinky Market

International Flavors & Fragrances is a top-quality name that now sits near a four-year low, despite being poised to set new earnings-per-share records this year and next.